Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Les Barons de la Bourse

Toute l'infoNos articlesSociétésMarchésEconomie & ForexMat. PremièresTauxBarons de la boursePro. de la financeAgendaSecteurs 
AccueilToute l'actualitéLes news les plus luesBiographies des Barons
Portrait de Richard L. Lindstrom
Age : 72
Patrimoine public : 2 273 549 USD
Principales sociétés : Ocular Therapeutix, Inc. - Harrow Health, Inc. - LENSAR, Inc.
Synthèse 
Richard L. Lindstrom is a businessperson who founded Minnesota Eye Consultants PA and Phillips Eye Institute and who has been at the head of 8 different companies.

He occupies the position of Chairman, President & Chief Executive Officer at Lindstrom Restoration, Medical Director at Sightpath Medical, Inc., Partner at Flying L Management LLC, Principal at Visionary Ventures Management LLC, Chief Executive Officer for Minnesota Eye Consultants PA and Medical Director at Midwest Surgical Services, Inc. Richard L. Lindstrom is also Chairman for American Society of Cataract & Refractive Surgery Foundation and Professor-Emeritus at the University of Minnesota and on the board of 21 other companies.

In the past Dr. Lindstrom was Chairman for Vision Foundation, Inc., President for International Refractive Surgery Club, Director & Chief Medical Officer at TLC Vision Corp., President of International Society of Refractive Surgery, Director at Refractec, Inc., President for International Intra-Ocular Implant Club, President at The American Society of Cataract & Refractive Surgery and Associate Director at Minnesota Lions Vision Foundation, Inc.

He received a doctorate and an undergraduate degree from The College of Liberal Arts at the University of Minnesota.


Postes et responsabilités de Richard L. Lindstrom 
Nom Titre Depuis
Ocular Therapeutix, Inc.
(Produits pharmaceutiques)
Independent Director 2012
Harrow Health, Inc.
(Produits pharmaceutiques)
Director 2015
LENSAR, Inc.
(Equipement et technologie médicale avancés)
Independent Director 2018
Lindstrom Restoration Chairman, President & Chief Executive Officer 1994
American Society of Cataract & Refractive Surgery Foundation Chairman -
Midwest Surgical Services, Inc. Medical Director -
Sightpath Medical, Inc. Medical Director -
AcuFocus, Inc. Director 2007
TherOptix, Inc. Director -
IOR Partners LLC Director 2021
Surface Pharmaceuticals, Inc. Director -
Surface Ophthalmics, Inc. Director -
IanTech, Inc. Director -
Aviana Molecular Technologies LLC Director -
American Society of Colon & Rectal Surgeons Trustee -
Unifeye Vision Partners Holdings LLC Director -
CorneaGen, Inc. Director -
Lindstrom Environmental, Inc. Director -
Encore Vision, Inc. Director -
Inner City Tennis Director -
RevitalVision LLC Director -
OCTANe Director -
Equinox Ophthalmic, Inc. Director -
American Academy of Ophthalmology, Inc. Director -
Minnesota Eye Consultants PA Chief Executive Officer 1983
WaveTec Vision Systems, Inc. Director -
University of Minnesota Professor-Emeritus 1989
Visionary Ventures Management LLC Principal -
Flying L Management LLC Partner -


Participations de Richard L. Lindstrom 
Nom Actions%Valorisation
Harrow Health, Inc. (HROW)
(Produits pharmaceutiques)
166 1000,62%1 675 949 USD
Ocular Therapeutix, Inc. (OCUL)
(Produits pharmaceutiques)
90 0000,12%597 600 USD
LENSAR, Inc. (LNSR)
(Equipement et technologie médicale avancés)
00,0000%0 USD


Richard L. Lindstrom: Réseau personnel 
Actualités les plus lues 
15/11PATRICK DRAHI : Le fondateur d'Altice, M. Drahi, cherche à augmenter sa participation dans le capital de la société britannique BT.
ZR
24/11ELON MUSK : Musk vend des actions Tesla d'une valeur de 1,05 milliard de dollars et achète 2,15 millions d'actions.
ZR
19/11PATRICK POUYANNÉ : Pas d'achat d'actifs renouvelables existants pour cause de bulle
RE
24/11BERNARD TAPIE : L'avenir de Stéphane Richard chez Orange suspendu à une décision de justice
RE
18/11PATRICK POUYANNÉ : Pas d'achat d'actifs renouvelables existants pour cause de bulle
RE
20/11VINCENT BOLLORÉ : Le groupe Dassault dément vouloir céder Le Figaro
RE
22/11ELON MUSK : USA-Les valeurs à suivre à Wall Street (actualisé)
RE
24/11JAMIE DIMON : Jamie Dimon plaisante en disant que JPMorgan survivra au parti communiste chinois.
ZR
21/11LUIGI GUBITOSI : KKR fait une offre non contraignante de $12 mds sur Telecom Italia
RE
25/11JAMIE DIMON : La Chine prend note des regrets du DG de JPMorgan
RE
Plus d'actualités


© 2021 People and Ownership :   
Richard L. Lindstrom : Connexions